CLINICAL_TRIALS ClinicalTrials.gov record update

Determination of Safety and Effectiveness of the SilverHawk™ Peripheral Plaque Excision System for Calcium (SilverHawk LS-C) and the SpiderFX™ Embolic Protection Device for the Treatment of Calcified Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries (DEFINITIVE Ca++)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT00733135
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:35:51.190881+00:00
Published At: 2014-07-04T00:00:00+00:00
Record Updated At: 2015-08-26
Results Posted At: 2014-07-04
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Peripheral Arterial Disease"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2015-08-26"
protocolSection.identificationModule.nctId: "NCT00733135"
protocolSection.identificationModule.officialTitle: "Determination of Safety and Effectiveness of the SilverHawk\u2122 Peripheral Plaque Excision System for Calcium (SilverHawk LS-C) and the SpiderFX\u2122 Embolic Protection Device for the Treatment of Calcified Peripheral Arterial Disease in the Superficial Femoral and/or the Popliteal Arteries (DEFINITIVE Ca++)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE2", "PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2014-07-04"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.